skip to main content

COVID-19 Information and Guidance

Stem Cell Therapies 2020: Are We There Yet?

Stem cell therapies offer great hope to patients with debilitating illnesses and injuries. However, only a limited number of therapies are approved for clinical use. At this event, a panel of experts described the stem cell therapy landscape. The discussants also highlighted the available treatments today, described why even negative clinical data can lead to new interventions, and evaluated recent incidents of unregulated stem cell use harming patients.

This event was part of an annual policy lecture series co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Heart Institute. Support for the program has been provided by a grant from the George and Mary Josephine Hamman Foundation

Follow @BakerCHB on Twitter and join the conversation online with #BakerStemCell.





7:30 a.m. — Reception
8:00 a.m. — Presentation


Laura Beil
Freelance Journalist and Host, "Dr. Death" and "Bad Batch" podcasts

Emerson C. Perin, M.D., Ph.D.
Medical Director, Texas Heart Institute


Fri, March 6, 2020
7:30 a.m. - 10 a.m.
(GMT-0500) US/Central


James A. Baker III Hall
Rice University's Baker Institute – 6100 Main St
Houston, TX 77005